8-K Announcements
6Material company update
May 13, 2026·SEC
Material company update
May 8, 2026·SEC
Material company update
Feb 18, 2026·SEC
Innospec Inc.(IOSP)Earnings, Financials & Key Ratios
IOSP•NASDAQ
17.7× P/E·Price updated Jun 19, 2026
SectorBasic MaterialsIndustrySpecialty ChemicalsSub-IndustrySpecialty additives and formulation chemicals
AboutInnospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, and metal extraction markets. The company's Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, as well as products to prevent loss of mud in drilling operations. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.Show more
- Revenue$1.78B-3.7%
- EBITDA$206M-7.1%
- Net Income$117M+227.5%
- EPS (Diluted)4.67+228.9%
- Gross Margin27.69%-5.9%
- EBITDA Margin11.56%-3.6%
- Operating Margin8.79%-8.8%
- Net Margin6.56%+239.9%
- ROE9.15%+204.0%
IOSP Key Insights
Innospec Inc. (IOSP) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y profit CAGR of 32.4%
- ✓12 consecutive years of dividend growth
- ✓Healthy dividend yield of 2.1%
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when IOSP posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
IOSP Price & Volume
Innospec Inc. (IOSP) stock price & volume — 10-year historical chart
Loading chart...
IOSP Growth Metrics
Innospec Inc. (IOSP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years5.79%
5 Years8.31%
3 Years-3.26%
TTM0.25%
Profit CAGR
10 Years-0.25%
5 Years32.36%
3 Years-4.29%
TTM322.96%
EPS CAGR
10 Years-0.4%
5 Years32.12%
3 Years-4.25%
TTM333.02%
Return on Capital
10 Years11.43%
5 Years12.69%
3 Years12.32%
Last Year11.02%
IOSP Recent Earnings
Innospec Inc. (IOSP) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 3/12 qtrs (25%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$1.05+2.9%
$1.02
Rev
$453M+4.9%
$432M
Q1 2026
Feb 17, 2026Metric
Actual
Est
EPS
$1.50+19.0%
$1.26
Rev
$456M-1.1%
$461M
Q4 2025
Nov 4, 2025Metric
Actual
Est
EPS
$1.12+8.7%
$1.03
Rev
$442M-4.1%
$461M
Q3 2025
Aug 5, 2025Metric
Actual
Est
EPS
$1.26+7.7%
$1.17
Rev
$440M-2.3%
$450M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $1.05vs $1.02+2.9% | $453Mvs $432M+4.9% |
| Q1 2026 | Feb 17, 2026 | $1.50vs $1.26+19.0% | $456Mvs $461M-1.1% |
| Q4 2025 | Nov 4, 2025 | $1.12vs $1.03+8.7% | $442Mvs $461M-4.1% |
| Q3 2025 | Aug 5, 2025 | $1.26vs $1.17+7.7% | $440Mvs $450M-2.3% |
Based on last 12 quarters of dataView full earnings history →
IOSP Peer Comparison
Innospec Inc. (IOSP) competitors in Specialty additives and formulation chemicals — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HWKN | 3.37B | 161.45 | 41.29 | 11.21% | 7.52% | 15.96% | 0.49 | |
 BCPC | 5.31B | 165.92 | 34.93 | 8.75% | 14.95% | 12.38% | 0.15 | |
 ITIC | 487.82M | 258.38 | 13.91 | 5.6% | 13.59% | 14.03% | 0.03 | |
 KWR | 2.6B | 150.18 | -1072.71 | 2.66% | 0.22% | 0.31% | 0.67 | |
 CBT | 4.79B | 91.80 | 15.25 | -7.04% | 7.97% | 16.75% | 0.71 | |
 ASIX | 535.41M | 19.86 | 11.03 | 0.31% | 0.67% | 1.28% | 0.47 | |
 ALB | 18.91B | 160.35 | -27.89 | -4.37% | -4.24% | -2.29% | 0.34 | |
 ECL | 76.01B | 269.12 | 36.97 | 2.16% | 12.91% | 21.96% | 0.96 |
Compare IOSP vs Peers
Innospec Inc. (IOSP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
IOSP Income Statement
Innospec Inc. (IOSP) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 1.31B | 1.48B | 1.51B | 1.19B | 1.48B | 1.96B | 1.95B | 1.85B | 1.78B | 1.79B |
Revenue Growth % | 47.93% | 13.02% | 2.46% | -21.16% | 24.33% | 32.38% | -0.76% | -5.31% | -3.65% | 0.25% |
Cost of Goods Sold | 903.5M | 1.04B | 1.05B | 850.4M | 1.05B | 1.38B | 1.36B | 1.3B | 1.29B | 1.3B |
COGS % of Revenue | 69.14% | 70.55% | 69.19% | 71.28% | 70.68% | 70.12% | 69.67% | 70.58% | 72.31% | - |
Gross Profit | 403.3M▲ 0% | 435M▲ 7.9% | 466.2M▲ 7.2% | 342.7M▼ 26.5% | 434.9M▲ 26.9% | 586.7M▲ 34.9% | 591.1M▲ 0.7% | 542.9M▼ 8.2% | 492.4M▼ 9.3% | 490.8M▲ 0% |
Gross Margin % | 30.86% | 29.45% | 30.81% | 28.72% | 29.32% | 29.88% | 30.33% | 29.42% | 27.69% | 27.41% |
Gross Profit Growth % | 21.37% | 7.86% | 7.17% | -26.49% | 26.9% | 34.9% | 0.75% | -8.15% | -9.3% | - |
Operating Expenses | 270.9M | 294.4M | 316.3M | 309M | 302.8M | 399.4M | 429.5M | 365M | 336.1M | 346.5M |
OpEx % of Revenue | 20.73% | 19.93% | 20.9% | 25.9% | 20.41% | 20.34% | 22.04% | 19.78% | 18.9% | - |
Selling, General & Admin | 239.5M | 261M | 280.9M | 237M | 267.2M | 360.7M | 387.8M | 314M | 285.1M | 294.3M |
SG&A % of Revenue | 18.33% | 17.67% | 18.56% | 19.86% | 18.01% | 18.37% | 19.9% | 17.02% | 16.03% | - |
Research & Development | 31.4M | 33.4M | 35.4M | 30.9M | 37.4M | 38.7M | 41.7M | 47.8M | 51M | 51.5M |
R&D % of Revenue | 2.4% | 2.26% | 2.34% | 2.59% | 2.52% | 1.97% | 2.14% | 2.59% | 2.87% | - |
Other Operating Expenses | 0 | 0 | 0 | 41.1M | -1.8M | 0 | 0 | 3.2M | 0 | 700K |
Operating Income | 129.7M▲ 0% | 133.5M▲ 2.9% | 149.9M▲ 12.3% | 33.7M▼ 77.5% | 132.1M▲ 292.0% | 187.3M▲ 41.8% | 161.6M▼ 13.7% | 177.9M▲ 10.1% | 156.3M▼ 12.1% | 144.3M▲ 0% |
Operating Margin % | 9.93% | 9.04% | 9.91% | 2.82% | 8.91% | 9.54% | 8.29% | 9.64% | 8.79% | 8.06% |
Operating Income Growth % | 23.05% | 2.93% | 12.28% | -77.52% | 291.99% | 41.79% | -13.72% | 10.09% | -12.14% | - |
EBITDA | 185.3M | 189.2M | 200.9M | 79.7M | 174.8M | 227.4M | 200.9M | 221.4M | 205.6M | 186.6M |
EBITDA Margin % | 14.18% | 12.81% | 13.28% | 6.68% | 11.78% | 11.58% | 10.31% | 12% | 11.56% | 10.42% |
EBITDA Growth % | 29.49% | 2.1% | 6.18% | -60.33% | 119.32% | 30.09% | -11.65% | 10.2% | -7.14% | -12.76% |
D&A (Non-Cash Add-back) | 55.6M | 55.7M | 51M | 46M | 42.7M | 40.1M | 39.3M | 43.5M | 49.3M | 42.3M |
EBIT | 136.3M | 138.5M | 155.2M | 41.5M | 130.3M | 187.3M | 161.6M | 181.1M | 156.3M | 125.4M |
Net Interest Income | -8.2M | -6.9M | -4.8M | -1.8M | -1.5M | -1.1M | 0 | 0 | 9.2M | 4.9M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.2M | 4.9M |
Interest Expense | 8.2M | 6.9M | 4.8M | 1.8M | 1.5M | 1.1M | 0 | 0 | 0 | 0 |
Other Income/Expense | -4.3M | -1.9M | 500K | 6M | 2.3M | -2.7M | 12.8M | -136.7M | -18.2M | -10.7M |
Pretax Income | 128.1M▲ 0% | 131.6M▲ 2.7% | 150.4M▲ 14.3% | 39.7M▼ 73.6% | 134.4M▲ 238.5% | 184.6M▲ 37.4% | 174.4M▼ 5.5% | 41.2M▼ 76.4% | 138.1M▲ 235.2% | 133.6M▲ 0% |
Pretax Margin % | 9.8% | 8.91% | 9.94% | 3.33% | 9.06% | 9.4% | 8.95% | 2.23% | 7.77% | 7.46% |
Income Tax | 66.3M | 46.6M | 38.2M | 11M | 41.3M | 51.6M | 35.3M | 5.6M | 21.5M | 19M |
Effective Tax Rate % | 51.76% | 35.41% | 25.4% | 27.71% | 30.73% | 27.95% | 20.24% | 13.59% | 15.57% | 14.22% |
Net Income | 61.8M▲ 0% | 85M▲ 37.5% | 112.2M▲ 32.0% | 28.7M▼ 74.4% | 93.1M▲ 224.4% | 133M▲ 42.9% | 139.1M▲ 4.6% | 35.6M▼ 74.4% | 116.6M▲ 227.5% | 114.2M▲ 0% |
Net Margin % | 4.73% | 5.76% | 7.41% | 2.41% | 6.28% | 6.77% | 7.14% | 1.93% | 6.56% | 6.38% |
Net Income Growth % | -23.99% | 37.54% | 32% | -74.42% | 224.39% | 42.86% | 4.59% | -74.41% | 227.53% | 322.96% |
Net Income (Continuing) | 61.8M | 85M | 112.2M | 28.7M | 93.1M | 133M | 139.1M | 35.6M | 116.6M | 114.6M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 400K | 500K | 400K | 500K | 600K | 2.4M | 2.5M | 4.9M | 6.8M | 7.2M |
EPS (Diluted) | 2.52▲ 0% | 3.45▲ 36.9% | 4.54▲ 31.6% | 1.16▼ 74.4% | 3.75▲ 223.3% | 5.32▲ 41.9% | 5.56▲ 4.5% | 1.42▼ 74.5% | 4.67▲ 228.9% | 4.60▲ 0% |
EPS Growth % | -24.32% | 36.9% | 31.59% | -74.45% | 223.28% | 41.87% | 4.51% | -74.46% | 228.87% | 333.02% |
EPS (Basic) | 2.56 | 3.48 | 4.58 | 1.17 | 3.78 | 5.37 | 5.60 | 1.43 | 4.69 | - |
Diluted Shares Outstanding | 24.49M | 24.6M | 24.73M | 24.78M | 24.85M | 24.98M | 25.02M | 25.12M | 24.99M | 24.84M |
Basic Shares Outstanding | 24.15M | 24.4M | 24.48M | 24.56M | 24.65M | 24.79M | 24.85M | 24.93M | 24.88M | 24.78M |
Dividend Payout Ratio | 30.1% | 25.53% | 22.28% | 89.2% | 30.93% | 23.83% | 25.23% | 108.99% | 36.36% | - |
IOSP Balance Sheet
Innospec Inc. (IOSP) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 561.5M | 663.9M | 630.3M | 566.2M | 728.1M | 872.6M | 885.7M | 956.6M | 1B | 999.1M |
Cash & Short-Term Investments | 90.2M | 123.1M | 75.7M | 105.3M | 141.8M | 147.1M | 203.7M | 289.2M | 292.5M | 289.1M |
Cash Only | 90.2M | 123.1M | 75.7M | 105.3M | 141.8M | 147.1M | 203.7M | 289.2M | 292.5M | 289.1M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 244.5M | 279.7M | 292M | 221.4M | 284.5M | 334.6M | 359.8M | 341.7M | 342.3M | 354.2M |
Days Sales Outstanding | 68.29 | 69.12 | 70.43 | 67.73 | 70 | 62.19 | 67.39 | 67.58 | 70.27 | 70.44 |
Inventory | 209.8M | 248M | 244.6M | 220M | 277.6M | 373.1M | 300.1M | 301M | 329.3M | 321.5M |
Days Inventory Outstanding | 84.76 | 86.88 | 85.26 | 94.43 | 96.64 | 98.9 | 80.68 | 84.35 | 93.49 | 93.58 |
Other Current Assets | 1.1M | 0 | 800K | 400K | 400K | 400K | 600K | 600K | 40.5M | 6.8M |
Total Non-Current Assets | 848.7M | 809.5M | 838.5M | 831.2M | 842.8M | 731.1M | 821.7M | 778.1M | 827.8M | 820.7M |
Property, Plant & Equipment | 196M | 196.4M | 231.1M | 250.9M | 249.8M | 266.2M | 313.4M | 314.5M | 338.8M | 336.3M |
Fixed Asset Turnover | 6.67x | 7.52x | 6.55x | 4.76x | 5.94x | 7.38x | 6.22x | 5.87x | 5.25x | 5.31x |
Goodwill | 361.8M | 364.9M | 363M | 371.2M | 364.3M | 358.8M | 399.3M | 382.5M | 399M | 399.1M |
Intangible Assets | 163.3M | 136.3M | 113.5M | 75.3M | 57.5M | 45M | 57.3M | 65.4M | 67.7M | 68.9M |
Long-Term Investments | 116M | 95.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 5.1M | 7.2M | 121.8M | 126.2M | 164.8M | 55.2M | 41.3M | 6.3M | 8.7M | 3.4M |
Total Assets | 1.41B▲ 0% | 1.47B▲ 4.5% | 1.47B▼ 0.3% | 1.4B▼ 4.9% | 1.57B▲ 12.4% | 1.6B▲ 2.1% | 1.71B▲ 6.5% | 1.73B▲ 1.6% | 1.83B▲ 5.6% | 1.82B▲ 0% |
Asset Turnover | 0.93x | 1.00x | 1.03x | 0.85x | 0.94x | 1.22x | 1.14x | 1.06x | 0.97x | 0.99x |
Asset Growth % | 19.37% | 4.48% | -0.31% | -4.86% | 12.42% | 2.09% | 6.47% | 1.6% | 5.63% | 14.5% |
Total Current Liabilities | 261.6M | 296.6M | 303.5M | 252.4M | 336.6M | 405.8M | 371.5M | 371.4M | 360.1M | 334.8M |
Accounts Payable | 117.9M | 126.8M | 122M | 98.7M | 148.7M | 165.3M | 163.6M | 163.8M | 174.7M | 138.5M |
Days Payables Outstanding | 47.63 | 44.42 | 42.53 | 42.36 | 51.76 | 43.82 | 43.98 | 45.9 | 49.6 | 43.87 |
Short-Term Debt | 15.8M | 21.4M | 0 | 0 | 0 | 0 | 0 | 0 | 15.9M | 15.1M |
Deferred Revenue (Current) | 100K | 8.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 5.1M | 5.9M | 5.6M | 6.6M | 5.2M | 5.3M | 5.8M | 5M | 164.2M | 176.9M |
Current Ratio | 2.15x | 2.24x | 2.08x | 2.24x | 2.16x | 2.15x | 2.38x | 2.58x | 2.79x | 2.98x |
Quick Ratio | 1.34x | 1.40x | 1.27x | 1.37x | 1.34x | 1.23x | 1.58x | 1.77x | 1.88x | 2.02x |
Cash Conversion Cycle | 105.42 | 111.58 | 113.17 | 119.8 | 114.88 | 117.27 | 104.08 | 106.03 | 114.16 | 120.15 |
Total Non-Current Liabilities | 354.3M | 351.3M | 246.4M | 200.1M | 201.3M | 157.5M | 186.3M | 147.2M | 139.4M | 132.8M |
Long-Term Debt | 202.6M | 186.2M | 58.6M | 0 | 0 | 0 | 0 | 0 | 36.8M | 0 |
Capital Lease Obligations | 3.2M | 1.5M | 22.4M | 29M | 23.1M | 31.4M | 31.6M | 31M | 36.8M | 139M |
Deferred Tax Liabilities | 45M | 48.2M | 49.6M | 46.9M | 60.8M | 26.2M | 33.5M | 23.5M | 19.1M | 61M |
Other Non-Current Liabilities | 103.1M | 115.4M | 115.8M | 124.2M | 117.4M | 99.9M | 121.2M | 92.7M | 46.7M | 79.4M |
Total Liabilities | 615.9M | 647.9M | 549.9M | 452.5M | 537.9M | 563.3M | 557.8M | 518.6M | 499.5M | 467.6M |
Total Debt | 224.3M | 210.9M | 92.6M | 40.8M | 35.6M | 45.3M | 45.2M | 44.9M | 89.5M | 50.6M |
Net Debt | 134.1M | 87.8M | 16.9M | -64.5M | -106.2M | -101.8M | -158.5M | -244.3M | -203M | -238.5M |
Debt / Equity | 0.28x | 0.26x | 0.10x | 0.04x | 0.03x | 0.04x | 0.04x | 0.04x | 0.07x | 0.04x |
Debt / EBITDA | 1.21x | 1.11x | 0.46x | 0.51x | 0.20x | 0.20x | 0.22x | 0.20x | 0.44x | 0.27x |
Net Debt / EBITDA | 0.72x | 0.46x | 0.08x | -0.81x | -0.61x | -0.45x | -0.79x | -1.10x | -0.99x | -1.28x |
Interest Coverage | 16.62x | 20.07x | 32.33x | 23.06x | 86.87x | 170.27x | - | - | - | - |
Total Equity | 794.7M▲ 0% | 826M▲ 3.9% | 918.9M▲ 11.2% | 944.9M▲ 2.8% | 1.03B▲ 9.3% | 1.04B▲ 0.7% | 1.15B▲ 10.5% | 1.22B▲ 5.8% | 1.33B▲ 9.6% | 1.35B▲ 0% |
Equity Growth % | 21.5% | 3.94% | 11.25% | 2.83% | 9.32% | 0.72% | 10.5% | 5.78% | 9.6% | 29.7% |
Book Value per Share | 32.46 | 33.57 | 37.16 | 38.13 | 41.56 | 41.65 | 45.94 | 48.41 | 53.33 | 54.43 |
Total Shareholders' Equity | 794.3M | 825.5M | 918.5M | 944.4M | 1.03B | 1.04B | 1.15B | 1.21B | 1.33B | 1.34B |
Common Stock | 300K | 300K | 300K | 300K | 300K | 300K | 300K | 300K | 300K | 300K |
Retained Earnings | 605M | 668.3M | 755.5M | 758.6M | 822.9M | 924.2M | 1.03B | 1.02B | 1.1B | 1.13B |
Treasury Stock | -93.3M | -92.8M | -93.3M | -93.3M | -90.6M | -95.4M | -94.3M | -93M | -115.2M | -121.4M |
Accumulated OCI | -38.5M | -75.7M | -74.4M | -57.3M | -46.9M | -145.2M | -148.1M | -91M | -34.7M | -40.8M |
Minority Interest | 400K | 500K | 400K | 500K | 600K | 2.4M | 2.5M | 4.9M | 6.8M | 7.2M |
IOSP Cash Flow Statement
Innospec Inc. (IOSP) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 82.7M | 104.9M | 161.6M | 145.9M | 93.2M | 81.7M | 207.3M | 184.5M | 138.3M | 127.6M |
Operating CF Margin % | 6.33% | 7.1% | 10.68% | 12.23% | 6.28% | 4.16% | 10.64% | 10% | 7.78% | - |
Operating CF Growth % | -20.86% | 26.84% | 54.05% | -9.72% | -36.12% | -12.34% | 153.73% | -11% | -25.04% | 152.44% |
Net Income | 61.8M | 85M | 112.2M | 28.7M | 93.1M | 133M | 139.1M | 35.6M | 116.6M | 114.2M |
Depreciation & Amortization | 50.4M | 49.6M | 47.6M | 46M | 42.7M | 40.1M | 39.3M | 43.5M | 43.6M | 42.6M |
Stock-Based Compensation | 4.1M | 4.9M | 26.7M | 5.8M | 4.4M | 6.7M | 8M | 8.5M | 8.1M | 4.1M |
Deferred Taxes | -6.7M | 5.5M | 0 | -2.5M | 6.4M | -5.5M | 3.6M | -39.3M | -10.2M | -300K |
Other Non-Cash Items | -1.9M | -5.3M | -4.1M | 17.8M | -5.3M | -2.5M | -3.3M | 155.1M | -19.8M | -12.1M |
Working Capital Changes | -25M | -34.8M | -20.8M | 50.1M | -48.1M | -90.1M | 20.6M | -18.9M | 0 | -20.9M |
Change in Receivables | -83.2M | -45.7M | -18.2M | 10.1M | -31.4M | -55.5M | -12.6M | 4.3M | 0 | -5.6M |
Change in Inventory | -30.8M | -42.2M | 2.4M | 25.5M | -62M | -98.5M | 83M | -11.8M | 0 | -9.7M |
Change in Payables | 48.6M | 38.4M | 0 | -45.9M | 90.2M | 54.2M | -26.9M | -4.5M | 0 | -17.7M |
Cash from Investing | -29.6M | -35.5M | -31M | -29.7M | -36.2M | -42.1M | -111.8M | -62M | -75.1M | -72M |
Capital Expenditures | -32.2M | -30.1M | -29.9M | -29.7M | -39.1M | -42.3M | -77.2M | -62.3M | -50.3M | -62.5M |
CapEx % of Revenue | 2.46% | 2.04% | 1.98% | 2.49% | 2.64% | 2.15% | 3.96% | 3.38% | 2.83% | 3.49% |
Acquisitions | 2.6M | -5.4M | 0 | 100K | 3M | 2M | -34.7M | -200K | -700K | 1.6M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -8.9M | -1.2M | -1.1M | -100K | -100K | -1.8M | 100K | 500K | -24.1M | -11.1M |
Cash from Financing | -66.4M | -36.2M | -177.9M | -86.8M | -20M | -33.7M | -39M | -35.3M | -63.9M | -68M |
Debt Issued (Net) | -53.5M | -14.2M | -150.2M | -61.1M | -600K | -100K | -2.3M | 0 | 0 | 0 |
Equity Issued (Net) | 5.7M | -300K | -2.4M | 100K | 9.3M | -3.7M | -200K | 1.4M | 0 | -26M |
Dividends Paid | -18.6M | -21.7M | -25M | -25.6M | -28.8M | -31.7M | -35.1M | -38.8M | -42.4M | -42.4M |
Share Repurchases | -1.1M | -1.4M | -2.4M | -2.1M | -800K | -5.9M | -1.1M | -700K | 0 | -26.2M |
Other Financing | 0 | 0 | -300K | -200K | 100K | 1.8M | -1.4M | 2.1M | -21.5M | 400K |
Net Change in Cash | -11.7M▲ 0% | 32.9M▲ 381.2% | -47.4M▼ 244.1% | 29.6M▲ 162.4% | 36.5M▲ 23.3% | 5.3M▼ 85.5% | 56.6M▲ 967.9% | 85.5M▲ 51.1% | 3.3M▼ 96.1% | -10.7M▲ 0% |
Free Cash Flow | 50.5M▲ 0% | 74.8M▲ 48.1% | 131.7M▲ 76.1% | 116.2M▼ 11.8% | 54.1M▼ 53.4% | 39.4M▼ 27.2% | 145.2M▲ 268.5% | 143.1M▼ 1.4% | 88M▼ 38.5% | 76.8M▲ 0% |
FCF Margin % | 3.86% | 5.06% | 8.7% | 9.74% | 3.65% | 2.01% | 7.45% | 7.75% | 4.95% | 4.29% |
FCF Growth % | -42.61% | 48.12% | 76.07% | -11.77% | -53.44% | -27.17% | 268.53% | -1.45% | -38.5% | -9% |
FCF per Share | 2.06 | 3.04 | 5.33 | 4.69 | 2.18 | 1.58 | 5.80 | 5.70 | 3.52 | 3.09 |
FCF Conversion (FCF/Net Income) | 1.34x | 1.23x | 1.44x | 5.08x | 1.00x | 0.61x | 1.49x | 5.18x | 1.19x | 0.67x |
Interest Paid | 0 | 0 | 4.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IOSP Key Ratios
Innospec Inc. (IOSP) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 8.53% | 10.49% | 12.86% | 3.08% | 9.41% | 12.83% | 12.7% | 3.01% | 9.15% | 8.64% |
Return on Invested Capital (ROIC) | 11.09% | 10.87% | 12.16% | 2.78% | 10.96% | 15.06% | 12.56% | 13.59% | 11.16% | 9.82% |
Gross Margin | 30.86% | 29.45% | 30.81% | 28.72% | 29.32% | 29.88% | 30.33% | 29.42% | 27.69% | 27.41% |
Net Margin | 4.73% | 5.76% | 7.41% | 2.41% | 6.28% | 6.77% | 7.14% | 1.93% | 6.56% | 6.38% |
Debt / Equity | 0.28x | 0.26x | 0.10x | 0.04x | 0.03x | 0.04x | 0.04x | 0.04x | 0.07x | 0.04x |
Interest Coverage | 16.62x | 20.07x | 32.33x | 23.06x | 86.87x | 170.27x | - | - | - | - |
FCF Conversion | 1.34x | 1.23x | 1.44x | 5.08x | 1.00x | 0.61x | 1.49x | 5.18x | 1.19x | 0.67x |
Revenue Growth | 47.93% | 13.02% | 2.46% | -21.16% | 24.33% | 32.38% | -0.76% | -5.31% | -3.65% | 0.25% |
Related:IOSP Dividend History·IOSP Revenue History·IOSP Price History·IOSP P/E History·IOSP Financial Ratios·IOSP Institutional Holders
IOSP SEC Filings & Documents
Innospec Inc. (IOSP) SEC filings — annual & quarterly reports (10-K, 10-Q)
IOSP Frequently Asked Questions
Innospec Inc. (IOSP) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Innospec Inc. (IOSP) reported $1.79B in revenue for fiscal year 2025. This represents a 285% increase from $465.0M in 1998.
Innospec Inc. (IOSP) saw revenue decline by 3.7% over the past year.
Yes, Innospec Inc. (IOSP) is profitable, generating $114.2M in net income for fiscal year 2025 (6.6% net margin).
Dividend & Returns
Yes, Innospec Inc. (IOSP) pays a dividend with a yield of 2.05%. This makes it attractive for income-focused investors.
Innospec Inc. (IOSP) has a return on equity (ROE) of 9.1%. This is below average, suggesting room for improvement.
Innospec Inc. (IOSP) generated $76.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.